Analysis of OHSU and TCGA (https://www.cbioportal.org/) data demonstrates the frequent presence of concurrent mutations in DNMT3A, FLT3, and TET2 genes in patients with AML. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.